back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-05-31 21:50 Tx date 2022-05-26 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,000,000 vol |
3,650,000 | |
| Filed 2022-05-31 21:48 Tx date 2022-05-26 |
$HAVN
HAVN Life Sciences Inc. |
Clissold, Gordon Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,150,000 | |
| Filed 2022-04-01 14:09 Tx date 2022-04-01 |
$HAVN
HAVN Life Sciences Inc. |
Clissold, Gordon Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,190
+17,000 vol $0.07 each |
30,500 | |
| Filed 2022-03-24 16:45 Tx date 2022-03-23 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+100,000 vol |
180,000 | |
| Filed 2022-03-24 16:44 Tx date 2022-03-23 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-100,000 vol |
10,000 | |
| Filed 2022-03-17 15:30 Tx date 2022-03-15 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,000,000 vol |
3,000,000 | |
| Filed 2022-03-17 15:29 Tx date 2022-03-15 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-1,000,000 vol |
750,000 | |
| Filed 2022-03-17 15:26 Tx date 2022-03-16 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
1,000,000 | |
| Filed 2022-03-17 15:25 Tx date 2022-03-16 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-500,000 vol |
0 | |
| Filed 2022-03-08 17:42 Tx date 2022-03-08 |
$HAVN
HAVN Life Sciences Inc. |
Staudt, Dennis Joseph
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+300,000 vol |
350,000 | |
| Filed 2022-02-15 19:25 Tx date 2022-02-15 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+500,000 vol |
1,750,000 | |
| Filed 2022-02-10 15:19 Tx date 2022-02-10 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+300,000 vol |
350,000 | |
| Filed 2022-02-10 15:16 Tx date 2022-02-09 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+110,000 vol |
110,000 | |
| Filed 2022-02-10 15:14 Tx date 2020-09-08 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-02-09 16:15 Tx date 2022-02-09 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2022-02-09 16:13 Tx date 2020-09-08 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-24 12:44 Tx date 2021-12-22 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+600,000 vol |
600,000 | |
| Filed 2021-12-24 12:43 Tx date 2020-05-05 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-24 12:42 Tx date 2021-12-22 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
650,000 | |
| Filed 2021-10-07 17:27 Tx date 2021-10-06 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+200,000 vol |
200,000 |